Skip to main
University-wide Navigation

UK Research Center Establishes Scholar Program to Promote Diversity in Neurotrauma Studies

Prendergast says statistics show that less than five percent of undergraduate neuroscience students in the U.S. are Black or African American, but at UK nearly ten percent of undergraduate neuroscience majors identify as Black or African American.

Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic

Researchers will be looking at a medication that recently received experimental approval from the USDA and its impact on the newly characterized form of dementia known as LATE. LATE is a disease with symptoms similar to Alzheimer’s disease.

Researchers Publish Study Looking at Approaches to Better Treat Alzheimer's Disease

For the past several decades, much of the work to find a treatment for AD has been focused on eliminating those dreaded Aβ plaques, by assuming that memory could be restored by removing the plaques.

UK Receives $3.2 Million for Traumatic Brain Injury Research

The National Institutes of Health award will fund ongoing research led by UK Neuroscience and Spinal Cord and Brain Injury Research Center (SCoBIRC) Professor Patrick Sullivan, Ph.D., who has studied the effects of the experimental drug MP201 on TBI.

UK Sanders-Brown Center on Aging Facilitates First Participant in Worldwide Drug Study

This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping it will ultimately help prevent Alzheimer’s disease.

Sanders-Brown Researcher Receives Grant Supported by Rotary Clubs to Further Dementia Studies

The $125,000 grant comes from The CART Fund. CART (Coins for Alzheimer’s Research Trust) is a grassroots effort by Rotary Club members throughout the country to provide cutting edge research to help find a cure for Alzheimer’s.

It’s Not Just Alzheimer’s Disease: Sanders-Brown Research Highlights Form of Severe Dementia

The long-running study on aging and brain health at UK’s Sanders-Brown Center on Aging (SBCoA) Alzheimer’s Disease Center has once again resulted in important new findings – highlighting a complex and under-recognized form of dementia.

UK Receives Prestigious Grant from National Institute of Neurological Disorders

The work at UK in Gentry’s lab supported by this award will focus on novel insights in energy metabolism using cutting edge methodologies applied to multiple human diseases.

Sanders-Brown Director Leads First Human Study of Drug Targeting Brain Inflammation

Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at UK, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced inflammation of the brain.

Free Radical Discovery a Hallmark of Allan Butterfield’s 45-Year Research Career

When you look back at a 45-year career, there are a multitude of moments that stand out. For Allan Butterfield, Professor of Biological Chemistry in the UK College of Arts & Sciences, his signature discovery grew from just such a Eureka moment on the sidewalk on campus. 

Filter News